Stem cells injected into brain of Alzheimer’s patients in world first
Key Points:
- A pioneering Alzheimer's treatment involving stem cells injected directly into the brain showed promising early results in a small trial of six patients, with five showing cognitive improvements and reductions in amyloid plaques and other biomarkers.
- The treatment uses stem cells derived from patients' own fat, grown and selected in the lab, then delivered into the brain via a small implanted reservoir, allowing potential repeated injections without further surgery.
- While the initial trial showed safety and encouraging biological changes, the study's small size and lack of a placebo group mean it cannot yet confirm the treatment's efficacy or long-term benefits.
- The US FDA has fast-tracked the program, and a larger Phase 2 trial is underway to assess whether repeated stem cell injections produce sustained cognitive improvements in Alzheimer's patients.
- Experts highlight that this approach differs from existing drugs by targeting multiple disease processes simultaneously, but emphasize that much larger controlled studies are needed to determine if it can meaningfully slow or reverse Alzheimer's progression.